LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

BACKGROUND: Randomized controlled trials (RCTs) indicate that long-acting bronchodilator combinations, such as β(2)-agonist (LABA)/muscarinic antagonist (LAMA), have favorable efficacy compared with commonly used COPD treatments. The objective of this analysis was to compare the efficacy and safety...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Chron Obstruct Pulmon Dis
Hlavní autoři: Rodrigo, Gustavo J, Price, David, Anzueto, Antonio, Singh, Dave, Altman, Pablo, Bader, Giovanni, Patalano, Francesco, Fogel, Robert, Kostikas, Konstantinos
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5364009/
https://ncbi.nlm.nih.gov/pubmed/28360514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S130482
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky